Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca PLC Director's Dealing 2013

Feb 27, 2013

5229_dirs_2013-02-27_57574840-7801-481f-9cea-8d6d3e0a3063.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7731Y

AstraZeneca PLC

27 February 2013

Transaction by Person Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

The interest of Simon Lowth, a Director of the Company, in AstraZeneca PLC Ordinary Shares of $0.25 each, has changed as detailed below. 

On 25 February 2013, Mr Lowth received an award of 11,728 shares under the AstraZeneca Deferred Bonus Plan. This award relates to the payment of his annual bonus whereby he is required to defer a portion of the bonus earned into shares for a period of three years.  The shares were awarded at a price of 2939 pence per share.  Mr Lowth will become beneficially entitled to these shares on 25 February 2016.

On 25 February 2013, Mr Lowth also received shares from the vesting of a previously announced award made in February 2010 under the AstraZeneca Deferred Bonus Plan whereby he has now become beneficially entitled to the shares.  Sufficient shares were withheld to cover certain tax obligations arising on the vesting.

Name of Director Number of shares vested Number of shares withheld Net number of shares Market price on vesting
Simon Lowth 9,760 5,076 4,684 2952.5p

As a result of these transactions, Mr Lowth has an interest in 298,051 Ordinary Shares, which represent approximately 0.02% of the Company's issued ordinary capital.

A C N Kemp

Company Secretary

27 February 2013

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSUBAKROWAUURR